Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic
More people are living longer with breast cancer – AI
Excited to share that Stratipath has been recognized as one
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic
Stratipath is happy to announce that one of the most
AI-precision oncology pioneers Stratipath have been awarded the Athena Prize,
Stratipath, today announced that Stratipath Breast has received CE marking
new validation data for prognostic performance of Stratipath Breast in
Helsinki University Hospital (HUS), Finland’s largest healthcare provider and one
First world health tech: Press Release Stratipath releases biopsy capability
The ESMO Daily Reporter recently published a summary of the
A method for spatial interpretation of weakly supervised deep learning
